Emergent Biosolutions
EBS
EBS
162 hedge funds and large institutions have $141M invested in Emergent Biosolutions in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 54 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
-21
Holders Change %
-11.48%
% of All Funds
2.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
47
Reduced
54
Closed
46
Calls
$314K
Puts
$580K
Net Calls
-$266K
Net Calls Change
+$178K
Top Buyers
| 1 |
Millennium Management
New York
|
$12.5M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
$8.26M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$4.08M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
$1.91M |
| 5 |
Squarepoint
New York
|
$2M |
